Well, it's not an intestinal carb-blocker, but SGLT2 inhibitors have been a subject of some excitement in the field of diabetic research...
Canaglifozin was recent approved conditionally for use in the U.S. - Invalid Link Removed
It blocks the renal re-absorption of glucose, so you literally pee out a portion of excess carbs.